Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
08/2000
08/24/2000CA2361925A1 Treatment of chronic viral infections with m. vaccae
08/24/2000CA2359610A1 Malaria vaccine
08/23/2000EP1029044A1 Tissue cement proteins from rhipicephalus appendiculatus
08/23/2000EP1028977A2 Bifidus stimulating peptides
08/23/2000EP1028722A1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine
08/23/2000EP0805795B1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
08/23/2000CN1055697C Phospholipi derivatives containing higher elements of the Vth main group
08/22/2000US6107333 Parenteral paclitaxel in a stable non-toxic formulation
08/22/2000US6107316 Method for treating protozoal infections
08/22/2000CA2187409C Stable crystalline tetrahydrofolic acid salts
08/22/2000CA2031199C Antibacterial and antimalarial peptides
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047597A1 Avermectin derivatives
08/17/2000WO2000047220A1 Controlling protein levels in eucaryotic organisms
08/17/2000CA2362560A1 Controlling protein levels in eucaryotic organisms
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/16/2000EP1027892A2 Azithromycin combination for emesis control in dogs
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000CN1263526A Triazine derivatives, their production and use
08/16/2000CN1262927A Dihydroartemisinin preparation for controlling broad-spectrum malaria and its preparation method
08/15/2000US6103727 Pyrimidine derivatives and methods of making and using these derivatives
08/15/2000CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid
08/15/2000CA2046601C Production and use of anthelmintic agents and protective immunogens
08/10/2000WO2000046381A1 Recombinant expression of heterologous nucleic acids in protozoa
08/10/2000WO2000046373A1 Diagnostic and protective antigen gene sequences of ichthyophthirius
08/10/2000WO2000046344A2 Non-stochastic generation of genetic vaccines and enzymes
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000025810A3 Immunomodulatory factors for immunosuppressant and antiallergic treatment
08/10/2000CA2361551A1 Method for controlling liposome size
08/09/2000EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
08/09/2000CN1262620A Beta-Alkoxyacrylates against malaria
08/09/2000CN1262099A Albendazole emulsion
08/08/2000US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals
08/08/2000US6100241 Nucleic acids encoding an immunogenic fragment of eimeria lactate dehydrogenase (ldh) which will react with antiserum raised against the ldh; preparing a vector vaccine against coccidiosis; administering to prevent coccidiosis in birds
08/08/2000US6100067 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes
08/08/2000US6099843 Used to protect animals from diseases caused by parasitic helminths
08/03/2000WO2000044761A2 Ketolide antibiotics
08/03/2000WO2000044387A1 Organoboron compounds exhibiting anticoccidial activities
08/03/2000WO2000044358A2 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044334A2 Novel injectable muscle relaxant formulations
08/03/2000WO2000023105A3 Adjuvant systems and vaccines
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000DE19902924A1 Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen Use of organophosphorus compounds in the prophylactic and therapeutic treatment of infections
08/03/2000CA2360661A1 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/02/2000EP1023308A1 Inhibitors of nucleoside metabolism
08/01/2000US6096750 Furopyrimidines and methods of making and using the same derivatives
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096329 Synergistic mixture containing fipronil
07/2000
07/29/2000CA2290771A1 Azithromycin combination for emesis control in dogs
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000042990A1 Liposome formulations
07/27/2000WO2000023592A3 Minimal promoters and uses thereof
07/27/2000CA2361272A1 33 human secreted proteins
07/26/2000EP1022278A1 Tetracyclical derivatives from pyrimidine
07/26/2000EP1021549A2 SENSE mRNA THERAPY
07/26/2000EP1021181A1 Carboxylic acid indole inhibitors of chemokines
07/26/2000CN1261277A Novel substituted imidazole compounds
07/26/2000CN1054851C 3-aryl-pyrone derivatives and their preparing methods and uses as pesticides and herbicides
07/26/2000CN1054745C Antibiotic composition
07/25/2000US6093406 Vaccine for induction of immunity to malaria
07/25/2000US6093394 Vaginal lactobacillus medicant
07/20/2000WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response
07/20/2000WO2000041682A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
07/20/2000WO2000041473A2 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
07/20/2000WO2000021979A3 Cyclic tetrapeptide and their use as histone deacetylase inhibitor
07/20/2000CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response
07/20/2000CA2360366A1 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
07/19/2000EP1019396A1 Novel cycloalkyl substituted imidazoles
07/19/2000EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
07/19/2000CN1260796A Alkaloid halide salts of swainsonine and methods of use
07/19/2000CN1260793A 4-haloalkyl-3-heterocyclyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof
07/19/2000CN1260723A Oil in water vaccine composition
07/19/2000CN1260718A Antithelmintic compositions
07/19/2000CN1054507C Preparation method for medicinal composition for treatment of vaginal infections
07/18/2000US6090579 Human SDR2 cDNA clone
07/18/2000US6090394 For humans, animals
07/18/2000US6090382 Human antibodies that bind human TNFα
07/18/2000CA2193870C Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen
07/13/2000WO2000040714A2 Therapeutic phosphodiesterase inhibitors
07/13/2000WO2000040243A1 Novel compounds
07/13/2000WO2000014217A3 G-motif oligonucleotides and uses thereof
07/13/2000WO2000010582A3 Probiotic, lactic acid-producing bacteria and uses thereof
07/13/2000CA2357950A1 Therapeutic phosphodiesterase inhibitors
07/12/2000EP1017806A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases
07/12/2000EP1017397A1 Photosensitizer conjugates for pathogen targeting
07/12/2000CN1259955A C-4'-substituted macrolide derivatives
07/12/2000CN1259874A Vaginal lactobacillus medicant
07/12/2000CN1259869A Pharmaceutical compositions contg. cinchonine dichlorhydrate
07/11/2000US6087365 Treating drug-resistant malaria in a mammal
07/06/2000WO2000039298A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum
07/06/2000WO2000038700A1 Antiprotozoal saponins
07/06/2000WO2000038697A1 Treatment and prevention of hiv and other viral infections
07/06/2000WO2000038687A1 Protease inhibitors
07/06/2000WO2000015770A3 Human serine/threonine protein kinases
07/06/2000CA2356671A1 Protease inhibitors
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 218